May 19, 2020 / 1:26 AM / 15 days ago

BRIEF-Innovent Biologics Enters Strategic Collaboration Agreement With University Of Texas MD Anderson Cancer Center

May 19 (Reuters) - Innovent Biologics Inc:

* INNOVENT BIOLOGICS INC- ENTERED INTO A STRATEGIC COLLABORATION AGREEMENT WITH UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER

* INNOVENT BIOLOGICS - AGREEMENT TO CO-DEVELOP TYVYT IN RARE CANCERS IN UNITED STATES

* INNOVENT BIOLOGICS INC- STUDIES WILL PROVIDE OPPORTUNITIES FOR CO TO PURSUE APPROVAL OF SINTILIMAB BY U.S. FDA FOR MULTIPLE RARE CANCER INDICATIONS Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below